Grundy and colleagues1 have elegantly quantified a practice that has garnered scant attention in the literature; that is, that pharmaceutical promotions reach well beyond the bounds of physicians and even other authorized prescribers, such as nurse practitioners (NPs). The findings that nonprescribing nurses were present at nearly 40% of pharmaceutical company–sponsored educational events in Australia between 2011 and 2015 were noteworthy, yet not at all surprising.
Ladd E, Hoyt A. Pharmaceutical Industry Interactions With Nonprescribing CliniciansA Complex Web of Influence. JAMA Intern Med. 2016;176(11):1720-1721. doi:10.1001/jamainternmed.2016.5284